// App-Quantinova.ai

216 : Modification of Structural Lesions on Magnetic Resonance Imaging by Etanercept: A 12- week Randomized Placebo-Controlled Trial

Researchers

Presenter

  • Stephanie Wichuk

Principal Investigators

  • Maxime Dougados

  • Heather Jones

  • Annette Szumski

  • Lisa Marshall

  • Jack Bukowski

  • Robert Lambert

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • Paris Descartes University, Paris, France

Locations

  • France

  • Canada

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Spondyloarthritis

  • Axial spondyloarthritis

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved